ghk-cu contraindications Copper Peptide Therapy Chicago Does GHK-Cu Really Work? 40

Some cited clinical trials are small

The primary risk with GHK-Cu is sourcing quality, as unregulated peptide products may contain impurities that cause reactions attributable to contamination rather than the peptide itself

C57BL/6 mice were treated with control chow or tesaglitazar-containing (TESA-containing) chow (0.5 mol/kg bw) for 6 weeks (all mice were treated in 1 experiment)

The fact that GHK was able to suppress 70% of genes involved in the development of an aggressive metastatic form of colon cancer indicates that GHK is capable of the regulation of various biochemical pathways on a gene level and it seems to be resetting the gene activity back to health, which leads to the improvement of tissue repair